nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Mesalazine—MPO—urinary bladder cancer	0.00699	0.368	CrCbGaD
Carbidopa—Mesalazine—PPARG—urinary bladder cancer	0.0062	0.327	CrCbGaD
Carbidopa—Epinephrine—TNF—urinary bladder cancer	0.00317	0.167	CrCbGaD
Carbidopa—Mesalazine—PTGS2—urinary bladder cancer	0.00262	0.138	CrCbGaD
Carbidopa—Pain—Cisplatin—urinary bladder cancer	0.00102	0.00104	CcSEcCtD
Carbidopa—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Carbidopa—Dizziness—Thiotepa—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Carbidopa—Urticaria—Fluorouracil—urinary bladder cancer	0.001	0.00102	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—urinary bladder cancer	0.000999	0.00102	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—urinary bladder cancer	0.000998	0.00102	CcSEcCtD
Carbidopa—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000997	0.00102	CcSEcCtD
Carbidopa—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000985	0.001	CcSEcCtD
Carbidopa—Paraesthesia—Etoposide—urinary bladder cancer	0.000984	0.001	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—urinary bladder cancer	0.000983	0.001	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—urinary bladder cancer	0.000977	0.000996	CcSEcCtD
Carbidopa—Dyspnoea—Etoposide—urinary bladder cancer	0.000977	0.000996	CcSEcCtD
Carbidopa—Somnolence—Etoposide—urinary bladder cancer	0.000974	0.000993	CcSEcCtD
Carbidopa—Vomiting—Thiotepa—urinary bladder cancer	0.00097	0.000989	CcSEcCtD
Carbidopa—Rash—Thiotepa—urinary bladder cancer	0.000962	0.00098	CcSEcCtD
Carbidopa—Dermatitis—Thiotepa—urinary bladder cancer	0.000961	0.000979	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00096	0.000979	CcSEcCtD
Carbidopa—Headache—Thiotepa—urinary bladder cancer	0.000955	0.000974	CcSEcCtD
Carbidopa—Decreased appetite—Etoposide—urinary bladder cancer	0.000952	0.000971	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000946	0.000964	CcSEcCtD
Carbidopa—Body temperature increased—Cisplatin—urinary bladder cancer	0.000945	0.000964	CcSEcCtD
Carbidopa—Fatigue—Etoposide—urinary bladder cancer	0.000945	0.000963	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000944	0.000962	CcSEcCtD
Carbidopa—Pain—Etoposide—urinary bladder cancer	0.000937	0.000955	CcSEcCtD
Carbidopa—Constipation—Etoposide—urinary bladder cancer	0.000937	0.000955	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000936	0.000954	CcSEcCtD
Carbidopa—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000929	0.000947	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000929	0.000947	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—urinary bladder cancer	0.000928	0.000946	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—urinary bladder cancer	0.000924	0.000942	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000923	0.000941	CcSEcCtD
Carbidopa—Asthenia—Gemcitabine—urinary bladder cancer	0.000921	0.000938	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000912	0.00093	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—urinary bladder cancer	0.000909	0.000927	CcSEcCtD
Carbidopa—Pruritus—Gemcitabine—urinary bladder cancer	0.000908	0.000925	CcSEcCtD
Carbidopa—Nausea—Thiotepa—urinary bladder cancer	0.000906	0.000923	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—urinary bladder cancer	0.000905	0.000923	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—urinary bladder cancer	0.000904	0.000922	CcSEcCtD
Carbidopa—Feeling abnormal—Etoposide—urinary bladder cancer	0.000903	0.00092	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000899	0.000916	CcSEcCtD
Carbidopa—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000896	0.000913	CcSEcCtD
Carbidopa—Pruritus—Fluorouracil—urinary bladder cancer	0.000893	0.00091	CcSEcCtD
Carbidopa—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000881	0.000898	CcSEcCtD
Carbidopa—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000878	0.000895	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000873	0.00089	CcSEcCtD
Carbidopa—Urticaria—Etoposide—urinary bladder cancer	0.00087	0.000887	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—urinary bladder cancer	0.000869	0.000886	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—urinary bladder cancer	0.000867	0.000883	CcSEcCtD
Carbidopa—Abdominal pain—Etoposide—urinary bladder cancer	0.000866	0.000883	CcSEcCtD
Carbidopa—Body temperature increased—Etoposide—urinary bladder cancer	0.000866	0.000883	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000866	0.000883	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—urinary bladder cancer	0.000864	0.000881	CcSEcCtD
Carbidopa—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000863	0.00088	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00086	0.000877	CcSEcCtD
Carbidopa—Asthenia—Cisplatin—urinary bladder cancer	0.000858	0.000875	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000854	0.00087	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—urinary bladder cancer	0.000847	0.000864	CcSEcCtD
Carbidopa—Dizziness—Fluorouracil—urinary bladder cancer	0.000834	0.00085	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000831	0.000848	CcSEcCtD
Carbidopa—Diarrhoea—Cisplatin—urinary bladder cancer	0.000818	0.000834	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—urinary bladder cancer	0.000816	0.000832	CcSEcCtD
Carbidopa—Vomiting—Gemcitabine—urinary bladder cancer	0.000816	0.000832	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—urinary bladder cancer	0.000809	0.000825	CcSEcCtD
Carbidopa—Rash—Gemcitabine—urinary bladder cancer	0.000809	0.000825	CcSEcCtD
Carbidopa—Dermatitis—Gemcitabine—urinary bladder cancer	0.000808	0.000824	CcSEcCtD
Carbidopa—Hypersensitivity—Etoposide—urinary bladder cancer	0.000807	0.000823	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000804	0.000819	CcSEcCtD
Carbidopa—Headache—Gemcitabine—urinary bladder cancer	0.000804	0.000819	CcSEcCtD
Carbidopa—Flushing—Epirubicin—urinary bladder cancer	0.000802	0.000818	CcSEcCtD
Carbidopa—Vomiting—Fluorouracil—urinary bladder cancer	0.000802	0.000818	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—urinary bladder cancer	0.000802	0.000817	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—urinary bladder cancer	0.0008	0.000815	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000796	0.000811	CcSEcCtD
Carbidopa—Rash—Fluorouracil—urinary bladder cancer	0.000795	0.000811	CcSEcCtD
Carbidopa—Dermatitis—Fluorouracil—urinary bladder cancer	0.000795	0.00081	CcSEcCtD
Carbidopa—Headache—Fluorouracil—urinary bladder cancer	0.00079	0.000806	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00079	0.000805	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—urinary bladder cancer	0.000787	0.000803	CcSEcCtD
Carbidopa—Asthenia—Etoposide—urinary bladder cancer	0.000786	0.000801	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000784	0.000799	CcSEcCtD
Carbidopa—Back pain—Methotrexate—urinary bladder cancer	0.000778	0.000793	CcSEcCtD
Carbidopa—Pruritus—Etoposide—urinary bladder cancer	0.000775	0.00079	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—urinary bladder cancer	0.000764	0.000779	CcSEcCtD
Carbidopa—Nausea—Gemcitabine—urinary bladder cancer	0.000762	0.000777	CcSEcCtD
Carbidopa—Vomiting—Cisplatin—urinary bladder cancer	0.00076	0.000775	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—urinary bladder cancer	0.000758	0.000772	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—urinary bladder cancer	0.000757	0.000772	CcSEcCtD
Carbidopa—Rash—Cisplatin—urinary bladder cancer	0.000754	0.000769	CcSEcCtD
Carbidopa—Dermatitis—Cisplatin—urinary bladder cancer	0.000753	0.000768	CcSEcCtD
Carbidopa—Diarrhoea—Etoposide—urinary bladder cancer	0.00075	0.000764	CcSEcCtD
Carbidopa—Nausea—Fluorouracil—urinary bladder cancer	0.000749	0.000764	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000746	0.00076	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—urinary bladder cancer	0.000743	0.000758	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—urinary bladder cancer	0.000742	0.000757	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—urinary bladder cancer	0.000741	0.000756	CcSEcCtD
Carbidopa—Tension—Epirubicin—urinary bladder cancer	0.000738	0.000753	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—urinary bladder cancer	0.000737	0.000751	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—urinary bladder cancer	0.000731	0.000745	CcSEcCtD
Carbidopa—Back pain—Epirubicin—urinary bladder cancer	0.000728	0.000742	CcSEcCtD
Carbidopa—Malaise—Methotrexate—urinary bladder cancer	0.000725	0.000739	CcSEcCtD
Carbidopa—Dizziness—Etoposide—urinary bladder cancer	0.000724	0.000739	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—urinary bladder cancer	0.000723	0.000737	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—urinary bladder cancer	0.00072	0.000734	CcSEcCtD
Carbidopa—Nausea—Cisplatin—urinary bladder cancer	0.00071	0.000724	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—urinary bladder cancer	0.000709	0.000723	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—urinary bladder cancer	0.000707	0.00072	CcSEcCtD
Carbidopa—Cough—Methotrexate—urinary bladder cancer	0.000702	0.000715	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—urinary bladder cancer	0.000701	0.000714	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000698	0.000712	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—urinary bladder cancer	0.000697	0.00071	CcSEcCtD
Carbidopa—Vomiting—Etoposide—urinary bladder cancer	0.000697	0.00071	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—urinary bladder cancer	0.000696	0.000709	CcSEcCtD
Carbidopa—Agitation—Epirubicin—urinary bladder cancer	0.000692	0.000705	CcSEcCtD
Carbidopa—Rash—Etoposide—urinary bladder cancer	0.000691	0.000704	CcSEcCtD
Carbidopa—Dermatitis—Etoposide—urinary bladder cancer	0.00069	0.000704	CcSEcCtD
Carbidopa—Headache—Etoposide—urinary bladder cancer	0.000686	0.0007	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—urinary bladder cancer	0.000686	0.000699	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—urinary bladder cancer	0.000685	0.000698	CcSEcCtD
Carbidopa—Tension—Doxorubicin—urinary bladder cancer	0.000683	0.000696	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000682	0.000695	CcSEcCtD
Carbidopa—Malaise—Epirubicin—urinary bladder cancer	0.000679	0.000692	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—urinary bladder cancer	0.000676	0.000689	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—urinary bladder cancer	0.000676	0.000689	CcSEcCtD
Carbidopa—Syncope—Epirubicin—urinary bladder cancer	0.000675	0.000688	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—urinary bladder cancer	0.000674	0.000687	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—urinary bladder cancer	0.000673	0.000687	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000669	0.000682	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—urinary bladder cancer	0.000665	0.000678	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—urinary bladder cancer	0.000662	0.000675	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000661	0.000674	CcSEcCtD
Carbidopa—Cough—Epirubicin—urinary bladder cancer	0.000657	0.000669	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—urinary bladder cancer	0.000656	0.000669	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—urinary bladder cancer	0.000652	0.000665	CcSEcCtD
Carbidopa—Infection—Methotrexate—urinary bladder cancer	0.000652	0.000665	CcSEcCtD
Carbidopa—Nausea—Etoposide—urinary bladder cancer	0.000651	0.000663	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—urinary bladder cancer	0.00065	0.000662	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000646	0.000659	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—urinary bladder cancer	0.000644	0.000656	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000643	0.000655	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—urinary bladder cancer	0.000641	0.000653	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—urinary bladder cancer	0.00064	0.000652	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—urinary bladder cancer	0.000638	0.000651	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000634	0.000647	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—urinary bladder cancer	0.000633	0.000645	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—urinary bladder cancer	0.000628	0.00064	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—urinary bladder cancer	0.000627	0.000639	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—urinary bladder cancer	0.000626	0.000638	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—urinary bladder cancer	0.000624	0.000636	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—urinary bladder cancer	0.000623	0.000635	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—urinary bladder cancer	0.000619	0.000631	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—urinary bladder cancer	0.000615	0.000627	CcSEcCtD
Carbidopa—Oedema—Epirubicin—urinary bladder cancer	0.000614	0.000626	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—urinary bladder cancer	0.000613	0.000625	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000612	0.000624	CcSEcCtD
Carbidopa—Infection—Epirubicin—urinary bladder cancer	0.00061	0.000622	CcSEcCtD
Carbidopa—Cough—Doxorubicin—urinary bladder cancer	0.000608	0.000619	CcSEcCtD
Carbidopa—Shock—Epirubicin—urinary bladder cancer	0.000604	0.000616	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—urinary bladder cancer	0.000603	0.000615	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000601	0.000613	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—urinary bladder cancer	0.000601	0.000613	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000594	0.000605	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—urinary bladder cancer	0.000594	0.000605	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—urinary bladder cancer	0.000593	0.000604	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—urinary bladder cancer	0.000591	0.000602	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—urinary bladder cancer	0.000589	0.000601	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—urinary bladder cancer	0.000586	0.000597	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—urinary bladder cancer	0.000585	0.000597	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—urinary bladder cancer	0.000585	0.000596	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—urinary bladder cancer	0.000583	0.000595	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—urinary bladder cancer	0.00058	0.000591	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—urinary bladder cancer	0.000578	0.000589	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—urinary bladder cancer	0.000574	0.000585	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—urinary bladder cancer	0.000573	0.000584	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—urinary bladder cancer	0.00057	0.000582	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—urinary bladder cancer	0.000568	0.000579	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000567	0.000578	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—urinary bladder cancer	0.000566	0.000577	CcSEcCtD
Carbidopa—Infection—Doxorubicin—urinary bladder cancer	0.000565	0.000575	CcSEcCtD
Carbidopa—Pain—Methotrexate—urinary bladder cancer	0.000561	0.000572	CcSEcCtD
Carbidopa—Shock—Doxorubicin—urinary bladder cancer	0.000559	0.00057	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000556	0.000567	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—urinary bladder cancer	0.000555	0.000566	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—urinary bladder cancer	0.000551	0.000562	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000549	0.00056	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—urinary bladder cancer	0.000548	0.000558	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—urinary bladder cancer	0.000546	0.000557	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—urinary bladder cancer	0.000542	0.000552	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000541	0.000551	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—urinary bladder cancer	0.000541	0.000551	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000537	0.000547	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—urinary bladder cancer	0.000534	0.000544	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—urinary bladder cancer	0.000531	0.000541	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00053	0.00054	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—urinary bladder cancer	0.000529	0.00054	CcSEcCtD
Carbidopa—Pain—Epirubicin—urinary bladder cancer	0.000525	0.000535	CcSEcCtD
Carbidopa—Constipation—Epirubicin—urinary bladder cancer	0.000525	0.000535	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—urinary bladder cancer	0.000521	0.000531	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—urinary bladder cancer	0.000519	0.000529	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—urinary bladder cancer	0.000519	0.000529	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—urinary bladder cancer	0.000514	0.000524	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00051	0.00052	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000507	0.000516	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000506	0.000516	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—urinary bladder cancer	0.000505	0.000515	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000502	0.000512	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—urinary bladder cancer	0.0005	0.00051	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000494	0.000504	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000491	0.0005	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—urinary bladder cancer	0.00049	0.000499	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—urinary bladder cancer	0.000488	0.000497	CcSEcCtD
Carbidopa—Pain—Doxorubicin—urinary bladder cancer	0.000486	0.000495	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—urinary bladder cancer	0.000486	0.000495	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—urinary bladder cancer	0.000485	0.000495	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—urinary bladder cancer	0.000485	0.000495	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000483	0.000493	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—urinary bladder cancer	0.000471	0.00048	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000468	0.000477	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000465	0.000474	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—urinary bladder cancer	0.000464	0.000473	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000452	0.000461	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—urinary bladder cancer	0.000451	0.00046	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000449	0.000458	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000449	0.000458	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—urinary bladder cancer	0.000449	0.000458	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—urinary bladder cancer	0.000441	0.000449	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—urinary bladder cancer	0.000434	0.000443	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—urinary bladder cancer	0.000434	0.000442	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—urinary bladder cancer	0.00042	0.000428	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000419	0.000427	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—urinary bladder cancer	0.000417	0.000425	CcSEcCtD
Carbidopa—Rash—Methotrexate—urinary bladder cancer	0.000414	0.000422	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—urinary bladder cancer	0.000413	0.000421	CcSEcCtD
Carbidopa—Headache—Methotrexate—urinary bladder cancer	0.000411	0.000419	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—urinary bladder cancer	0.000408	0.000416	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—urinary bladder cancer	0.000406	0.000414	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—urinary bladder cancer	0.000402	0.00041	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—urinary bladder cancer	0.00039	0.000398	CcSEcCtD
Carbidopa—Nausea—Methotrexate—urinary bladder cancer	0.00039	0.000397	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000389	0.000396	CcSEcCtD
Carbidopa—Rash—Epirubicin—urinary bladder cancer	0.000387	0.000395	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—urinary bladder cancer	0.000387	0.000394	CcSEcCtD
Carbidopa—Headache—Epirubicin—urinary bladder cancer	0.000385	0.000392	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—urinary bladder cancer	0.000376	0.000383	CcSEcCtD
Carbidopa—Nausea—Epirubicin—urinary bladder cancer	0.000365	0.000372	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—urinary bladder cancer	0.000361	0.000368	CcSEcCtD
Carbidopa—Rash—Doxorubicin—urinary bladder cancer	0.000358	0.000365	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—urinary bladder cancer	0.000358	0.000365	CcSEcCtD
Carbidopa—Headache—Doxorubicin—urinary bladder cancer	0.000356	0.000363	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—urinary bladder cancer	0.000338	0.000344	CcSEcCtD
